Credit Agricole’s Heron Therapeutics HRTX Stock Holding History

Credit Agricole’s Portfolio HRTX Stock Details HRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-142,200	Closed	-$3.48M	–	501
2019 Q1	$3.48M	Buy	142,200 +39,270	+38%	+$1.03M	0.19%	125
2018 Q4	$2.67M	Buy	102,930 +35,590	+53%	+$979K	0.15%	170
2018 Q3	$2.13M	Buy	67,340 +31,640	+89%	+$1.18M	0.1%	221
2018 Q2	$1.39M	Buy	35,700 +27,000	+310%	+$860K	0.1%	187
2018 Q1	$240K	Buy	+8,700	New	+$197K	0.02%	274

Other funds holding HRTX

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

Credit Agricole's HRTX Position: Q2 2019 in Review

Credit Agricole sold out of Heron Therapeutics (HRTX) in Q2 2019, closing a stake of 142,200 shares — an estimated $3.48M sold.

Credit Agricole first reported a position in HRTX in Q1 2018 and held it in 5 quarters. The position peaked at $3.48M in Q1 2019. 176 funds tracked by Wall St. Rank hold HRTX as of Q2 2019.

Credit Agricole reported no remaining Heron Therapeutics position as of Q2 2019 after selling out during the quarter.
Credit Agricole sold 142,200 Heron Therapeutics shares in Q2 2019, an estimated $3.48M.
Credit Agricole first reported a position in Heron Therapeutics in Q1 2018 and held it in 5 quarters.
Credit Agricole's Heron Therapeutics position peaked at $3.48M in Q1 2019.
176 funds tracked by Wall St. Rank held Heron Therapeutics as of Q2 2019.

Based on Credit Agricole's 13F filing for Q2 2019, filed 14 Aug 2019.